Brief: Aurinia Announces Management Transition
23/03/2026 12:08
Aurinia Pharmaceuticals Inc AUPH.O: AURINIA ANNOUNCES MANAGEMENT TRANSITION AURINIA PHARMACEUTICALS INC - APPOINTS KEVIN TANG AS CEO SUCCEEDING PETER GREENLEAF AURINIA PHARMACEUTICALS INC - APPOINTS MICHAEL HEARNE AS CFO Source text: ID:nBw2qBQjSa Further company coverage: AUPH.O
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death